Log In
BCIQ
Print this Print this
 

Tunex, Biosimilar etanercept

  Manage Alerts
Collapse Summary General Information
Company Mycenax Biotech Inc.
DescriptionBiosimilar of etanercept, a recombinant p75 tumor necrosis factor (TNF) receptor linked to the Fc portion of human IgG1 (TNFr:Fc)
Molecular Target Tumor necrosis factor (TNF) alpha ; Fc gamma receptor I (FCGR1) (CD64)
Mechanism of ActionTumor necrosis factor (TNF) alpha inhibitor; Biosimilar
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentRegistration
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation
PartnerTSH Biopharm Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today